Related Experiment Video
Updated: Jul 12, 2025

12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
1.1K
The Art of Immunotherapy
1Department of Medicine, Division of Allergy/Immunology, National Jewish Health, Denver, Colo.
The Journal of Allergy and Clinical Immunology. in Practice
|October 28, 2023
Summary
Choosing allergy immunotherapy (AIT) involves assessing allergen causality and symptom severity. The paper guides decisions on subcutaneous immunotherapy versus sublingual immunotherapy (SLIT) tablets, addressing practical management challenges for effective treatment.
Area of Science:
- Allergy and Immunology
- Clinical Medicine
- Pharmacology
Background:
- Allergy immunotherapy (AIT) selection requires careful patient evaluation.
- Key considerations include allergen sensitization, exposure patterns, and symptom severity.
- Patient motivation, whether for symptom relief or disease modification, influences treatment choice.
Purpose of the Study:
- To provide a comprehensive guide for clinicians on selecting and managing patients undergoing allergy immunotherapy.
- To address critical decision points in AIT, including allergen choice, administration route, and potential challenges.
- To optimize patient adherence and treatment outcomes in AIT.
Main Methods:
- Review of clinical guidelines and expert opinion on allergy immunotherapy.
- Analysis of factors influencing the choice between subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
- Discussion of practical management strategies for adverse reactions, treatment gaps, and adherence.
Main Results:
- AIT selection hinges on establishing a causal link between allergen exposure and symptoms.
- Sublingual immunotherapy (SLIT) tablets offer convenience but may be limited to fewer allergens compared to SCIT.
- Effective management of AIT involves addressing local/systemic reactions, treatment interruptions, and optimizing adherence.
Conclusions:
- The paper outlines a systematic approach to patient selection and management for allergy immunotherapy.
- It highlights the trade-offs between different AIT modalities, emphasizing individualized treatment strategies.
- Improving adherence and managing practical challenges are crucial for successful long-term AIT outcomes.
Related Concept Videos
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
Cancer Vaccines
383
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383
Cytotoxic T Cells-mediated Immune Response
933
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
933
Special Features of Adaptive Immunity
840
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
840
Cell-mediated Immune Responses
68.6K
Overview
68.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

